503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-23.76%
Revenue decline while CRWV shows 23.55% growth. Joel Greenblatt would examine competitive position erosion.
-24.06%
Cost reduction while CRWV shows 19.16% growth. Joel Greenblatt would examine competitive advantage.
-23.68%
Gross profit decline while CRWV shows 25.15% growth. Joel Greenblatt would examine competitive position.
0.09%
Margin expansion below 50% of CRWV's 1.30%. Michael Burry would check for structural issues.
6.78%
R&D change of 6.78% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
-2.62%
Both companies reducing G&A. Martin Whitman would check industry cost trends.
-11.49%
Marketing expense reduction while CRWV shows 248.84% growth. Joel Greenblatt would examine competitive risk.
-100.00%
Other expenses reduction while CRWV shows 19.33% growth. Joel Greenblatt would examine efficiency.
-4.45%
Operating expenses reduction while CRWV shows 17.97% growth. Joel Greenblatt would examine advantage.
-11.22%
Total costs reduction while CRWV shows 18.28% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
12.85%
D&A growth less than half of CRWV's 26.15%. David Dodd would verify if efficiency is sustainable.
-36.32%
EBITDA decline while CRWV shows 33.05% growth. Joel Greenblatt would examine position.
-14.61%
EBITDA margin decline while CRWV shows 7.69% growth. Joel Greenblatt would examine position.
-39.23%
Operating income decline while CRWV shows 169.93% growth. Joel Greenblatt would examine position.
-20.30%
Operating margin decline while CRWV shows 156.60% growth. Joel Greenblatt would examine position.
-54.59%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-39.87%
Pre-tax income decline while CRWV shows 9.63% growth. Joel Greenblatt would examine position.
-21.14%
Pre-tax margin decline while CRWV shows 26.86% growth. Joel Greenblatt would examine position.
-39.89%
Tax expense reduction while CRWV shows 3.78% growth. Joel Greenblatt would examine advantage.
-39.87%
Net income decline while CRWV shows 7.67% growth. Joel Greenblatt would examine position.
-21.13%
Net margin decline while CRWV shows 25.27% growth. Joel Greenblatt would examine position.
-38.67%
EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-39.19%
Diluted EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-1.00%
Share count reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.
-0.84%
Diluted share reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.